0000897069-18-000366.txt : 20180516
0000897069-18-000366.hdr.sgml : 20180516
20180516100118
ACCESSION NUMBER: 0000897069-18-000366
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20180516
DATE AS OF CHANGE: 20180516
EFFECTIVENESS DATE: 20180516
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001533743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451539785
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-312505
FILM NUMBER: 18839042
BUSINESS ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
BUSINESS PHONE: 443-776-3133
MAIL ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
FORMER COMPANY:
FORMER CONFORMED NAME: Heatwurx, Inc.
DATE OF NAME CHANGE: 20111028
D
1
primary_doc.xml
X0708
D
LIVE
0001533743
Processa Pharmaceuticals, Inc.
7380 COCA COLA DRIVE
SUITE 106
HANOVER
MD
MARYLAND
21076
443-776-3133
DELAWARE
Heatwurx, Inc.
Corporation
true
David
Young
7380 Coca Cola Drive
Suite 106
Hanover
MD
MARYLAND
21076
Executive Officer
Director
Patrick
Lin
7380 Coca Cola Drive
Suite 106
Hanover
MD
MARYLAND
21076
Executive Officer
Director
Justin
W.
Yorke
7380 Coca Cola Drive
Suite 106
Hanover
MD
MARYLAND
21076
Director
Virgil
Thompson
7380 Coca Cola Drive
Suite 106
Hanover
MD
MARYLAND
21076
Director
Sian
Bigora
7380 Coca Cola Drive
Suite 106
Hanover
MD
MARYLAND
21076
Executive Officer
Helen
Pentikis
7380 Coca Cola Drive
Suite 106
Hanover
MD
MARYLAND
21076
Executive Officer
Wendy
Guy
7380 Coca Cola Drive
Suite 106
Hanover
MD
MARYLAND
21076
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06c
false
2018-05-15
false
true
true
false
0
Boustead Securities, LLC
141391
None
None
6 Venture
Suite 325
Irvine
CA
CALIFORNIA
92618
AL
ALABAMA
AK
ALASKA
AZ
ARIZONA
AR
ARKANSAS
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
FL
FLORIDA
GA
GEORGIA
IL
ILLINOIS
IN
INDIANA
IA
IOWA
LA
LOUISIANA
MD
MARYLAND
MA
MASSACHUSETTS
MI
MICHIGAN
MN
MINNESOTA
MO
MISSOURI
NV
NEVADA
NJ
NEW JERSEY
NM
NEW MEXICO
NY
NEW YORK
NC
NORTH CAROLINA
OH
OHIO
OR
OREGON
PA
PENNSYLVANIA
SC
SOUTH CAROLINA
TN
TENNESSEE
TX
TEXAS
UT
UTAH
VA
VIRGINIA
WA
WASHINGTON
WI
WISCONSIN
false
Fintech Clearing, LLC
134742
None
None
6 Venture
Suite 325
Irvine
CA
CALIFORNIA
92618
AL
ALABAMA
AK
ALASKA
AZ
ARIZONA
AR
ARKANSAS
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
DE
DELAWARE
DC
DISTRICT OF COLUMBIA
FL
FLORIDA
GA
GEORGIA
HI
HAWAII
ID
IDAHO
IL
ILLINOIS
IN
INDIANA
IA
IOWA
KS
KANSAS
KY
KENTUCKY
LA
LOUISIANA
ME
MAINE
MD
MARYLAND
MA
MASSACHUSETTS
MI
MICHIGAN
MN
MINNESOTA
MS
MISSISSIPPI
MO
MISSOURI
MT
MONTANA
NE
NEBRASKA
NV
NEVADA
NH
NEW HAMPSHIRE
NJ
NEW JERSEY
NM
NEW MEXICO
NY
NEW YORK
NC
NORTH CAROLINA
ND
NORTH DAKOTA
OH
OHIO
OK
OKLAHOMA
OR
OREGON
PA
PENNSYLVANIA
RI
RHODE ISLAND
SC
SOUTH CAROLINA
SD
SOUTH DAKOTA
TN
TENNESSEE
TX
TEXAS
UT
UTAH
VT
VERMONT
VA
VIRGINIA
WA
WASHINGTON
WV
WEST VIRGINIA
WI
WISCONSIN
WY
WYOMING
false
8000000
2525694
5474306
If the warrants are exercised, the issuer may raise up to an additional $9,600,000.
false
33
480000
0
The Sales Commissions are based on Total Offering Amount being raised.
0
false
Processa Pharmaceuticals, Inc.
David Young
David Young
Chief Executive Officer
2018-05-15